Transcriptomic Insights into Hub Genes, Immune Infiltration, and Candidate Drugs in Erosive Esophagitis
Ye Zhao,Xi Chen,Yuhan Huang,Zhihan Zhang,Kui Wang,Duowu Zou,Teng Ma
DOI: https://doi.org/10.2147/jir.s479032
IF: 4.5
2024-10-28
Journal of Inflammation Research
Abstract:Ye Zhao, 1, &ast Xi Chen, 1, &ast Yuhan Huang, 2, &ast Zhihan Zhang, 3 Kui Wang, 1 Duowu Zou, 1 Teng Ma 2 1 Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 3 Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Teng Ma, Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China, Email Duowu Zou, Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, People's Republic of China, Email Purpose: This study aimed to investigate gene expression profiles, identify potential hub genes, and predict drugs for patients with erosive esophagitis (EE). Despite its clinical significance, molecular-level exploration of this condition has been limited. Patients and Methods: RNA sequencing was performed on clinical biopsy samples from eight EE patients and eight healthy controls. Integrated bioinformatic tools were then utilized to analyze the data, including functional enrichment analysis, protein-protein interaction network analysis, weighted gene co-expression network analysis, immune infiltration analysis, and identification of small-molecule compounds. Additionally, the expressions of the identified hub genes were assessed in clinical samples. Results: A total of 2801 genes with differential expression were identified, including four potential hub genes: SOX9, SPP1, TIMP1, and TLR4. Moreover, the overexpression of these hub genes was verified in clinical samples. Analysis of Immune infiltration indicated an imbalance in the distribution of immune cell types in patients with EE. Correlation analysis between immune cells and hub genes unveiled noteworthy relationships. Specifically, SOX9 exhibited a negative correlation with CD8 T cells but a positive correlation with resting memory CD4 T cells. SPP1 displayed a positive correlation with naïve B cells, while TIMP1 exhibited a negative correlation with resting dendritic cells. Furthermore, the study identified ten small-molecule drugs with potential therapeutic effects for EE, including loreclezole and mercaptopurine. Conclusion: This study provides valuable insights into the molecular understanding of EE, offering new perspectives on disease mechanisms. The findings may inspire further research leading to the development of novel treatment strategies for EE. Keywords: erosive esophagitis, RNA sequencing, bioinformatics analysis, immune infiltration, drug prediction Gastroesophageal reflux disease (GERD) is widely considered the most prevalent digestive disorder among adults, posing a significant public health issue. 1,2 Patients with GERD commonly manifest symptoms such as distressing heartburn, effortless regurgitation, and additional complications, causing challenges in clinical management. 3 A recent systematic review of nearly one hundred studies revealed its worldwide average prevalence of 13.3%. 4 GERD has two primary subtypes, non-erosive reflux disease (NERD) and erosive esophagitis (EE), mainly based on the presence or absence of macroscopic erosions. 5 By performing endoscopy, clinicians can diagnose GERD patients with esophageal mucosal breaks or ulcerations as having EE and grade its severity from A (mild) to D (severe) according to the Los Angeles (LA) classification system. 6,7 The understanding of the pathogenesis of GERD has undergone a significant transformation from a conventional "top-down" model to the later "bottom-up" concept, commonly referred to as the "cytokine sizzle". 8,9 The theory of cytokine-driven mucosal injury suggests that cytokine secretion triggered by reflux sets in motion the development of esophagitis. 9 The esophageal mucosa acts as the first defense against the noxious refluxate, playing a pivotal role in the pathogenesis of GERD. Recent advances in exploring how the aggressive components of the refluxate lead to mucosal inflammation have contributed to the current integrated view of pathogenesis of GERD mucosa, which includes changes in the permeability of the esophageal epithelial barrier, activation of nociceptive nerves, and inflammation mediated by cytokines. 9 Heterogeneity of reflux components and causal factors can af -Abstract Truncated-
immunology